Overview
Hiroshi Horii practices in Japan. Mr. Horii is rated as an Advanced expert by MediFind in the treatment of Pulmonary Artery Agenesis. His top areas of expertise are Pulmonary Artery Agenesis, Glycogen Storage Disease Type 6, Severe Acute Respiratory Syndrome (SARS), and COVID-19.
His clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pulmonary Artery Agenesis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Glycogen Storage Disease Type 6Mr. Horii isAdvanced. Learn about Glycogen Storage Disease Type 6.
- Pulmonary Artery AgenesisMr. Horii isAdvanced. Learn about Pulmonary Artery Agenesis.
- Experienced
- Acute Interstitial PneumoniaMr. Horii isExperienced. Learn about Acute Interstitial Pneumonia.
- Bronchiolitis ObliteransMr. Horii isExperienced. Learn about Bronchiolitis Obliterans.
- COVID-19Mr. Horii isExperienced. Learn about COVID-19.
- Interstitial Lung DiseaseMr. Horii isExperienced. Learn about Interstitial Lung Disease.
- PneumoniaMr. Horii isExperienced. Learn about Pneumonia.
- Severe Acute Respiratory Syndrome (SARS)